CVI Investments, Inc. 13D and 13G filings for Ensysce Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 11:20 am Sale | 2022-12-31 | 13G | Ensysce Biosciences, Inc. ENSC | CVI Investments, Inc. | 1,872 4.900% | -906 (-32.63%) | Filing |
| 2022-12-16 10:24 am Purchase | 2022-12-07 | 13G | Ensysce Biosciences, Inc. ENSC | CVI Investments, Inc. | 2,778 7.800% | 2,778 (New Position) | Filing |